MSD Korea's Cholesterol Absorption Inhibitor Now Available

Published: 2005-01-24 06:55:00

Updated: 2005-01-24 06:55:00

Six months after obtaining a market approval by the Korea Food and Drug Administration (KFDA), MSD Korea officially announced that Ezetrol, a cholesterol absorption inhibitor, is now available in the domestic market.

According to the company, Ezetrol (active ingredient: ezetimibe) is regarde...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK